Company profile
Glactone Pharma AB company profile
Glactone Pharma is founded on research that has demonstrated that the natural product galiellalactone can inhibit the growth of prostate cancer cells. With these results as the starting point the company has focused on discovering and developing novel drug-like compounds that display efficacious and selective STAT3 inhibition in vitro and in specific immune-oncology and prostate cancer models.
Business identity
- Website
- https://www.glactone.com/
- Operating status
- Closed
- Company type
- For Profit
- Founded
- 2012-01-01
Headquarters
- Headquarters
- Helsingborg, Skane Lan, Sweden
- Country code
- SE
- Continent
- Europe